Understanding Common GLP-1 Side Effects: A Patient's Perspective When Lili Zarghami walked out of her doctors office with a free box of Mounjaro a glucagon-like peptide-1 (GLP-1) agonist from Eli Lilly she felt hopeful that the drug might help her shed extra pounds she had gained related to having polycystic ovary syndrome (PCOS)
No existe dependencia farmacolgica, pero algunos pacientes pueden mostrar apego psicolgico al medicamento debido a la mejora rpida del control glucmico y peso.
The words and other content provided in this blog, and in any linked materials, are not intended and should not be construed as medical advice
For instance, in November 2023, results from the SELECT trial published in the New England Journal of Medicine showed that once-weekly semaglutide 2.4 mg reduced the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease without diabetes, highlighting the expanding role of long-acting GLP-1 analogues beyond glycemic control into cardiovascular risk reduction
v3.0 Pillar-by-Pillar Score Six Named Partner Pharmacies Empower Pharmacy Texas, 503A + 503B